Portland Investment Counsel Inc. Point Biopharma Global Inc. Transaction History

Portland Investment Counsel Inc.

  • $258 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$6.67 - $9.71 $622,311 - $905,943
-93,300 Reduced 82.35%
20,000 $133,000
Q2 2023

Aug 14, 2023
BUY
$6.86 - $10.86 $683,942 - $1.08 Million
99,700 Added 733.09%
113,300 $1.03 Million
Q4 2022

Feb 14, 2023
BUY
$5.72 - $9.78 $77,792 - $133,008
13,600 New
13,600 $99,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Portland Investment Counsel Inc. Portfolio

Follow Portland Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email